Pinkas Jan Insider Trades & Stock Holdings

Chief Scientific Officer · Crescent Biopharma, Inc. · Latest filing Sep 16, 2026

Pinkas Jan, Chief Scientific Officer at Crescent Biopharma, Inc. has 1 Form 4 trade on file since Sep 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($11.78K), net -$11.78K. Latest filing: disposed of 658 shares of $CBIO on Sep 16, 2026 at $17.90.

Trades on file

1

Open-market bought

$0

Open-market sold

$11.78K

Net open-market

-$11.78K

Latest filing

Sep 16, 2026

All insider trades by Pinkas Jan

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 16, 2026	$CBIO	Sell (Open-market sale) 10b5-1	658	$17.90	$11.78K						Chief Scientific Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Pinkas Jan traded

• $CBIO

Frequently asked questions

Has Pinkas Jan been buying or selling stock?

Pinkas Jan has 0 open-market purchases and 1 open-market sale on file, net -$11.78K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Pinkas Jan's latest insider trade?

disposed of 658 shares of $CBIO on Sep 16, 2026 at $17.90.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.